John Libbey Eurotext

Annales de Biologie Clinique

Recommandations pour l’analyse du liquide céphalorachidien au cours des leucémies aiguës Volume 75, numéro 5, Septembre-Octobre 2017

  • [1] Mahmoud H.H., Rivera G.K., Hancock M.L., Krance R.A., Kun L.E., Behm F.G. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329:314-319.
  • [2] Cherlow J.M., Sather H., Steinherz P., Gaynon P., Tubergen D., Trigg M. Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group. Int J Radiat Oncol Biol Phys. 1996;36:19-27.
  • [3] Pullern J., Boyett J., Schuster J., Crist W., Land V., Frankel L. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good risk and poor risk patients with B-progenitor acute lymphoblastic leukemia: a pediatric Oncology Group Study. J Clin Oncol. 1993;11:839-849.
  • [4] Reman O., Pigneux A., Huguet F., Vey N., Delannoy A., Fegueux N. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from GELT-LALA group. Leuk Res. 2008;32:1741-1750.
  • [5] Lazarus H.M., Richards S.M., Chopra R., Litzow M.R., Burnett A.K., Wiernick P.H. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII /ECOG E2993. Blood. 2006;108:465-472.
  • [6] Petersdorf S.H., Kopecky K.J., Head D.R., Bold D.H., Balcerzak S.P., Wun T. Comparison of the L10M consolidation regimen to an alternative regimen including escalading methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study in adults. Leukemia. 2001;15:208-216.
  • [7] Hoelzer D., Thiel E., Löffler H., Büchner T., Ganser A., Heil G. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71:123-131.
  • [8] Rees J.K., Gray R.G., Swirsky D., Hayhoe F.G. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet. 1986;2:1236-1241.
  • [9] Fiere D., Lepage E., Sebban C., Boucheix C., Gisselbrecht C., Vernant J.P. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. J Clin Oncol. 1993;11:1990-2001.
  • [10] Odom L.F., Wilson H., Cullen J., Bank J., Blake M., Jamieson B. Significance of blasts in low-cell-count cerebrospinal fluid specimens from children with acute lymphoblastic leukemia. Cancer. 1990;66:1748-1754.
  • [11] Sanz M.A., Grimwade D., Tallman M.S., Lowenberg B., Fenaux P., Estey E.H. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood. 2009;113:1875-1891.
  • [12] Döhner H., Estey E.H., Amadori S., Appelbaum F.R., Buchner T., Burnett A.K. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453-474.
  • [13] Johnston D.L., Alonzo T.A., Gerbing R.B., Lange B.J., Woods W.G. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer. 2010;55:414-420.
  • [14] Bommer M., Von Harsdorf S., Döhner H., Bunjes D., Ringhoffer M. Neoplastic meningitidis in patients with acute myeloid leukemia scheduled for allogenic hematopoietic stem cell transplantation. Haematologica. 2010;95:1969-1972.
  • [15] Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the medical research council. AML10 and 12 trials for acute myeloïd leukemia. Blood 2001 ; 98 : 1714-20.
  • [16] Reiter A., Schrappe M., Ludwig W.D., Hiddemann W., Sauter S., Henze G. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicentre trial ALL-BFM 86. Blood. 1994;84:3122-3133.
  • [17] Kantarjian H.M., Walters R.S., Smith T.L., Keating M.J., Barlogie B., McCredie K.B. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood. 1998;72:1784-1789.
  • [18] Pui C.H., Howard S.C. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9:257-268.
  • [19] Thomas X., Payan L., Le Q.H. Leucemies aiguës lymphoblastiques de l’adulte avec envahissement du système nerveux central : mise au point. Bull Cancer. 2008;95:707-715.
  • [20] Pui C.H., Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol. 2009;36:S2-S16.
  • [21] Mastrangelo R., Poplack D., Bleyer A., Riccardi R., Sather H., D’Angio G. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol. 1986;14:191-194.
  • [22] Pui C.H., Mahmoud H.H., Rviera G.K., Hancock M.L., Sandlund J.T., Behm F.G. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998;92:411-415.
  • [23] Bürger B., Zimmermann M., Mann G., Kühl J., Löning L., Riehm H. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21:184-188.
  • [24] Loeb K.R., Cherian S., Becker P.S., Walter R.B., Pagel J.M., Abkowitz J.L. Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukemia cells in cerebrospinal fluid. Br J Haematol. 2016;172:134-136.
  • [25] Inukai T., Akahane K., Nemoto A., Kuroda I., Noguchi S., Hirose K. Revision of the cytological diagnosis of CNS relapse into aseptic meningitis in a patient with TEL-AML1+ acute lymphoblastic leukemia by FISH analysis of mononuclear cells in cerebrospinal fluid. Histopathology. 2007;50:947-949.
  • [26] Scrideli C.A., Queiroz R.P., Takayanagui O.M., Bernardes J.E., Tone L.G. Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol. 2003;12:124-127.
  • [27] Price R.A., Johnson W.W. The central nervous system in childhood leukemia. I. The arachnoid. Cancer. 1973;31:520-533.
  • [28] Bleyer W.A., Coccia P.F., Sather H.N., Level C., Lukens J., Niebrugge D.J. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. J Clin Oncol. 1983;1:317-325.
  • [29] Azzarelli B., Mirkin L.D., Goheen M., Muller J., Crockett C. The leptomeningeal vein. A site of re-entry of leukemic cells into systemic circulation. Cancer. 1984;54:1333-1343.
  • [30] Pinkel D., Woo S. Prevention and treatment of meningeal leukemia in children. Blood. 1994;84:355.
  • [31] Evans A., Gilbert E.S., Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer. 1970;26:404-409.
  • [32] Smith M., Arthur D., Camitta B., Carroll A.J., Crist W., Gaynon P. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14:18-24.
  • [33] Glantz M.J., Cole B.F., Glantz L.K., Cobb J., Mills P., Lekos A. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733-739.
  • [34] Craig F.E., Ohori P., Gorrill T.S., Swerdlow S. Flow cytometric immunophenotyping of cerebrospinal fluid specimens. Am J Clin Pathol. 2011;135:22-34.
  • [35] Operators manual for Cytospin 3 (74010121 GB - appendix 1) and 4 (A 78310250 - appendix B) SHANDON « Use of the Cytospin for hematology and other clinical microscopy specimens » Appendix 1 (cytospin 3) and appendix B (cytospin 4). https://www.thermofisher.com/order/catalog/product/. (consulté le 13 mai 2017)
  • [36] Steele RW, Marmer DJ, O’Brien M, Tyson ST and Steele CR. Leukocyte survival in cerebrospinal fluid. J Clin Microbiol 1986 ; 23 : 965-6.
  • [37] Gajjar A., Harrison P.L., Sandlund J.T., Rivera G.K., Ribeiro R.C., Rubnitz J.E. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96:3381-3384.
  • [38] Ranchere-Vince D., Vielh P. Diagnostic pitfalls in CSF cytology. Ann Pathol. 1999;19:450-456.
  • [39] Paris A., Nhan T., Cornet E., Perol J.P., Malet M., Troussard X. Performance evaluation of the body fluid mode on the platform Sysmex XE-5000 series automated hematology analyser. Int J Lab Hematol. 2010;32:539-547.